Form 8-K Context Therapeutics For: Oct 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities climb as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil inches higher, stays near six-month highs on Saudi attacks
- Britain will not join Canada-led defence bank initiative
Context Therapeutics expands share offering program to $75 million
October 24, 2025 4:04 PM EDTContext Therapeutics Inc. (NASDAQ: CNTX) amended its at-the-market equity offering program on October 24, 2025, expanding the aggregate offering amount to $75 million from its previous limit, according to a company statement.
The biotechnology company entered into Amendment No. 1 to its existing Sales Agreement with... More



